Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 98028219 | 9802821 | 9 | F | 201307 | 20160217 | 20140108 | 20160912 | EXP | US-ROCHE-1329252 | ROCHE | 67.89 | YR | F | Y | 0.00000 | 20160912 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 98028219 | 9802821 | 1 | PS | RITUXAN | RITUXIMAB | 1 | Intravenous (not otherwise specified) | 2 WEEKS APART AND THEN 6 MONTHS LATER 2 WEEKS APART | U | 103705 | SOLUTION FOR INFUSION | ||||||||
| 98028219 | 9802821 | 2 | SS | RITUXAN | RITUXIMAB | 1 | Intravenous (not otherwise specified) | U | 103705 | SOLUTION FOR INFUSION | |||||||||
| 98028219 | 9802821 | 3 | SS | ACTEMRA | TOCILIZUMAB | 1 | Unknown | ^7 ONCE A WEEK^ | 125276 | 2.5 | MG | /wk | |||||||
| 98028219 | 9802821 | 4 | C | FOLIC ACID. | FOLIC ACID | 1 | Unknown | 0 | 1 | MG | QD | ||||||||
| 98028219 | 9802821 | 5 | C | METHOTREXATE. | METHOTREXATE | 1 | Unknown | 7 ONCE A WEEK | 0 | 2.5 | MG | /wk | |||||||
| 98028219 | 9802821 | 6 | C | GABAPENTIN. | GABAPENTIN | 1 | Unknown | 0 | 300 | MG | TID | ||||||||
| 98028219 | 9802821 | 7 | C | LASIX | FUROSEMIDE | 1 | Unknown | OD | 0 | 20 | MG | ||||||||
| 98028219 | 9802821 | 8 | C | PANTOPRAZOLE | PANTOPRAZOLE SODIUM | 1 | Unknown | 0 | 40 | MG | BID | ||||||||
| 98028219 | 9802821 | 9 | C | ALBUTEROL. | ALBUTEROL | 1 | Oral | 0 | 4 | MG | BID | ||||||||
| 98028219 | 9802821 | 10 | C | SINGULAIR | MONTELUKAST SODIUM | 1 | Unknown | 0 | 10 | MG | QD | ||||||||
| 98028219 | 9802821 | 11 | C | PERFOROMIST | FORMOTEROL FUMARATE DIHYDRATE | 1 | Unknown | 0 | BID | ||||||||||
| 98028219 | 9802821 | 12 | C | PULMICORT NEBULIZER | 2 | Unknown | 0 | QD | |||||||||||
| 98028219 | 9802821 | 13 | C | IPRATROPIUM BROMIDE NEBULIZER | 2 | Unknown | 0 | BID | |||||||||||
| 98028219 | 9802821 | 14 | C | ADVAIR HFA | FLUTICASONE PROPIONATESALMETEROL XINAFOATE | 1 | Unknown | 0 | 500 | MG | BID | ||||||||
| 98028219 | 9802821 | 15 | C | QVAR | BECLOMETHASONE DIPROPIONATE | 1 | Unknown | 0 | 80 | UG | BID | ||||||||
| 98028219 | 9802821 | 16 | C | COUMADIN | WARFARIN SODIUM | 1 | 0 | ||||||||||||
| 98028219 | 9802821 | 17 | C | JANUVIA | SITAGLIPTIN PHOSPHATE | 1 | 0 | ||||||||||||
| 98028219 | 9802821 | 18 | C | ZANTAC | RANITIDINE HYDROCHLORIDE | 1 | Unknown | 0 | 150 | MG | QD | ||||||||
| 98028219 | 9802821 | 19 | C | RANITIDINE. | RANITIDINE | 1 | Unknown | HS | 0 | 150 | MG | ||||||||
| 98028219 | 9802821 | 20 | C | SIMVASTATIN. | SIMVASTATIN | 1 | Unknown | HS | 0 | 20 | MG | ||||||||
| 98028219 | 9802821 | 21 | C | PREDNISONE. | PREDNISONE | 1 | Unknown | 0 | 20 | MG | BID | ||||||||
| 98028219 | 9802821 | 22 | C | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 98028219 | 9802821 | 1 | Rheumatoid arthritis |
| 98028219 | 9802821 | 3 | Rheumatoid arthritis |
| 98028219 | 9802821 | 5 | Rheumatoid arthritis |
| 98028219 | 9802821 | 6 | Neuropathy peripheral |
| 98028219 | 9802821 | 7 | Fluid retention |
| 98028219 | 9802821 | 8 | Gastrooesophageal reflux disease |
| 98028219 | 9802821 | 18 | Gastrooesophageal reflux disease |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 98028219 | 9802821 | HO |
| 98028219 | 9802821 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 98028219 | 9802821 | Asthma | |
| 98028219 | 9802821 | Blood glucose increased | |
| 98028219 | 9802821 | Bronchitis | |
| 98028219 | 9802821 | Bronchospasm | |
| 98028219 | 9802821 | Candida infection | |
| 98028219 | 9802821 | Cough | |
| 98028219 | 9802821 | Diabetes mellitus | |
| 98028219 | 9802821 | Dry mouth | |
| 98028219 | 9802821 | Dyspnoea | |
| 98028219 | 9802821 | Gastric perforation | |
| 98028219 | 9802821 | Malaise | |
| 98028219 | 9802821 | Nasopharyngitis | |
| 98028219 | 9802821 | Oesophagitis | |
| 98028219 | 9802821 | Osteonecrosis | |
| 98028219 | 9802821 | Pulmonary embolism | |
| 98028219 | 9802821 | Pulmonary eosinophilia | |
| 98028219 | 9802821 | Respiratory disorder | |
| 98028219 | 9802821 | Respiratory distress | |
| 98028219 | 9802821 | Respiratory tract infection | |
| 98028219 | 9802821 | Sinusitis | |
| 98028219 | 9802821 | Speech disorder | |
| 98028219 | 9802821 | Tongue ulceration | |
| 98028219 | 9802821 | Ulcer | |
| 98028219 | 9802821 | Wheezing |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 98028219 | 9802821 | 1 | 20130701 | 0 | ||
| 98028219 | 9802821 | 2 | 2014 | 0 |